quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:57:01·483d
SECFiling
The Duckhorn Portfolio Inc. logo

The Duckhorn Portfolio Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement

NAPA· The Duckhorn Portfolio Inc.
Consumer Staples
Original source

Companies

  • NAPA
    The Duckhorn Portfolio Inc.
    Consumer Staples

Recent analyst ratings

  • Dec 6UpdateJefferies$11.00
  • Oct 11UpdateRBC Capital Mkts-
  • Apr 18UpdateBarclays$8.00
  • Feb 13UpdateBofA Securities$8.00
  • Dec 7UpdateBofA Securities$11.00
  • Nov 13UpdateJefferies$13.00

Related

  • SEC472d
    SEC Form 15-12G filed by The Duckhorn Portfolio Inc.
  • SEC476d
    SEC Form EFFECT filed by The Duckhorn Portfolio Inc.
  • INSIDER482d
    Large owner Mallard Holdco, Llc disposed of $681,590,605 worth of shares (61,404,559 units at $11.10), closing all direct ownership in the company (SEC Form 4)
  • INSIDER483d
    Former 10% Owner Marlee Buyer, Inc. returned $70,794,945 worth of shares to the company (6,377,923 units at $11.10), closing all direct ownership in the company (SEC Form 4)
  • SEC483d
    Amendment: SEC Form SCHEDULE 13D/A filed by The Duckhorn Portfolio Inc.
  • INSIDER483d
    Officer Fall Jung Jennifer returned $112,454 worth of shares to the company (91,532 units at $1.23), closing all direct ownership in the company (SEC Form 4)
  • INSIDER483d
    Director O'Hara James L. returned $3,426,970 worth of shares to the company (308,736 units at $11.10), closing all direct ownership in the company (SEC Form 4)
  • INSIDER483d
    Officer Mahlan Deirdre returned $6,924,513 worth of shares to the company (623,830 units at $11.10) and converted options into 177,095 shares (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022